Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Current Deferred Revenue (2020 - 2025)

HealthLynked (HLYK) has disclosed Current Deferred Revenue for 6 consecutive years, with $47735.0 as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue fell 77.57% to $47735.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $47735.0, a 77.57% decrease, with the full-year FY2024 number at $232545.0, down 14.43% from a year prior.
  • Current Deferred Revenue was $47735.0 for Q3 2025 at HealthLynked, down from $155212.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $575843.0 in Q1 2023 to a low of $30535.0 in Q3 2021.
  • A 5-year average of $203433.1 and a median of $197769.0 in 2023 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: surged 1626.77% in 2023, then plummeted 77.57% in 2025.
  • HealthLynked's Current Deferred Revenue stood at $47838.0 in 2021, then surged by 1101.65% to $574847.0 in 2022, then plummeted by 52.72% to $271774.0 in 2023, then dropped by 14.43% to $232545.0 in 2024, then crashed by 79.47% to $47735.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Current Deferred Revenue are $47735.0 (Q3 2025), $155212.0 (Q2 2025), and $218054.0 (Q1 2025).